Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: cancer and infectious disease therapeutics - Caliber Biotherapeutics

Next Previous
X
Search
Drug Profile

Research programme: cancer and infectious disease therapeutics - Caliber Biotherapeutics

Alternative Names: Infectious disease vaccines - Caliber Biotherapeutics; Pandemic influenza vaccine - Caliber Biotherapeutics/DARPA; Plant-made pharmaceuticals (PMP) based biobetter mAb candidates - Caliber Biotherapeutics; Rituxan biobetter candidate for cancer - Caliber Biotherapeutics; Rituximab biobetter candidates - Caliber Biotherapeutics

Latest Information Update: 28 Jul 2018

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Caliber Biotherapeutics
  • Developer Caliber Biotherapeutics; Defense Advanced Research Projects Agency
  • Class Biobetters; Influenza A vaccines; Monoclonal antibodies; Vaccines
  • Mechanism of Action Antibody-dependent cell cytotoxicity; B cell inhibitors; CD20 antigen inhibitors; Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Cancer; Influenza A virus infections

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for research development in Cancer in USA (Parenteral)
  • 28 Jul 2018 No recent reports of development identified for research development in Influenza-A-virus-infections(Prevention) in USA (Parenteral)
  • 13 Jun 2013 Early research for Cancer is ongoing in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top